Looking at the SNP's in Clinvar, for example http://www.ncbi.nlm.nih.gov/clinvar/variation/11/, I see that the SNP NM_000410.3(HFE):c.193A>T (p.Ser65Cys) (also known as rs1800730) corresponds to the disease hemochromatosis. Since we have 2 alleles, that means the genotype possibilities are AA, AT, or TT. From the ClinVar data, is it possible to see which genotype are associated with the disease? I assume that since we have a A to T mutation, then T must be the pathogenic allele. So, does this mean TT is worse than AT which is worse than AA?
-
Last edited by leontp587; 11-18-2014, 01:37 PM. -
I have the same question. Could anyone can explain?Originally posted by leontp587 View Post -
Hello,
whether AT or TT is needed to be pathogenic depends on the mode of inheritance. Is it dominant than it is enough if one allele has T, if it is recessive you need TT (or a second mutation in the gene on the other allele).
In clinvar you find under "Condition(s)" links to OMIM, where you can read about the inheritance.
fin swimmerComment
-
You may also want to expand the text in "Summary evidence" (on the Illumina and Invitae rows).Comment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment